• Skip to main content
  • Skip to primary sidebar

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login

Portfolio

/ July 31, 2020

Techmer PM

Techmer PM

Techmer PM is a materials design company that specializes in modifying and fine-tuning the properties of technical polymers. The Company partners and collaborates with plastics processors, fabricators, designers, specifiers and brand owners. Drawing on a broad portfolio of resins –– from polyolefins to PEEK –– Techmer PM helps manufacturers enhance product function and appearance in numerous end‐use markets. The Company operates seven North American plants, and has extensive experience in a broad range of plastics and fiber‐related processes, from additive manufacturing and blown film to nonwovens, injection molding and sheet extrusion.

SK Capital established a strategic partnership with Techmer PM in July 2020.

For more information, please visit www.techmerpm.com

Primary Sidebar

Latest News

  • SK Capital Announces Asim Bhatia as Director, Business Development

    June 23, 2022
  • SK Capital Announces Richard Jackson as Managing Director

    May 23, 2022
  • SK Capital Announces the Acquisition of Florachem

    May 2, 2022

SK Capital Portfolio Companies

  • Florachem
  • Heubach
  • Seqens
  • Deltech LLC
  • Canlak
  • IPACKCHEM
  • Woodstock Sterile Solutions
  • Lacerta Group
  • Venator
  • Tilley
  • NuCera Solutions
  • Techmer PM
  • GEON
  • SI Group
  • Perimeter Solutions
  • Wavelength
  • Foremark
  • Tri-Tex
  • Niacet
  • Noramco
  • Extractas Bioscience
  • Purisys
  • Archroma
  • Addivant
  • TPC Group
  • Ascend
  • IBA Molecular
  • Calabrian Corporation
  • Halo Pharmaceutical
  • AEB Group

To request for a copy of our ESG report, please click here.

© 2022 SK Capital Partners. All Rights Reserved.

Important Disclosures

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
    • Back
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
    • Back
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
    • Back
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login